Sixty‐seven cases of small cell lung carcinoma (SCLA) in Tri‐Service General Hospital
(TSGH) during the past 16 years were studied. For patients with extensive stage of disease …

Pretreatment classification of patients with small cell carcinoma of the lung into categories of
“limited” and “extensive” disease is inadequate; it does not identify the few having a good …

A series of 1019 patients with small cell carcinoma of the lung, treated at the Department of
Radiotherapy and Oncology at the Helsinki University Central Hospital during the period …

Small cell carcinoma of the lung is notable for extreme malignancy in clinical behavior, with
rapid growth, wide dissemination, and short survival after treatment. It is highly responsive to …

Combined modality therapy is the standard care for limited stage-small cell lung cancer (LS-
SCLC) and has led to a significant improvement in patients' survival. This study sought to …

Small-cell lung carcinoma (SCLC) is a rapidly progressive and fatal disease. Historically,
surgical resection or radiotherapy of the primary tumor has done little to prolong survival …

The morphological differentiation between small-cell and non-small-cell lung cancer has
great prognostic and therapeutic significance for the patient. Malignant lung tumors are now …

Introduction For more than 50 years, small cell lung cancer (SCLC) has been staged mainly
as either limited or extensive stage disease. Small published series of resected SCLC have …

Small cell lung cancer (SCLC) is a distinct and well-reproducible histopathological entity
(Hirsch et al. 1982). Besides morphological criteria, SCLC is distinguished from other cell …

BACKGROUND: Prognosis is incompletely known for small-cell lung carcinoma (SCLC)
detected by CT screening of at-risk subjects. METHODS: A multinational study of baseline …